Literature DB >> 23412673

Osteoarthritis guidelines: a progressive role for topical NSAIDs.

Steven Stanos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23412673

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN： 0098-6151


× No keyword cloud information.
  5 in total

1.  Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis.

Authors:  Nemat Z Yassin; Siham M El-Shenawy; Rehab F Abdel-Rahman; Mostafa Yakoot; Mohamed Hassan; Sherine Helmy
Journal:  Drug Des Devel Ther       Date:  2015-03-12       Impact factor: 4.162

Review 2.  Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.

Authors:  Roy Altman; Bill Bosch; Kay Brune; Paola Patrignani; Clarence Young
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

3.  Topical Effects of Artemisia Absinthium Ointment and Liniment in Comparison with Piroxicam Gel in Patients with Knee Joint Osteoarthritis: A Randomized Double-Blind Controlled Trial.

Authors:  Zahra Basiri; Fatemeh Zeraati; Farzaneh Esna-Ashari; Farshid Mohammadi; Keyvan Razzaghi; Malihe Araghchian; Shirin Moradkhani
Journal:  Iran J Med Sci       Date:  2017-11

4.  Therapeutic Use of Scoparia dulcis Reduces the Progression of Experimental Osteoarthritis.

Authors:  Marcus Vinícius Viégas Lima; Abner de Oliveira Freire; Emerson Lucas Frazão Sousa; André Alvares Marques Vale; Alberto Jorge Oliveira Lopes; Cleydlenne Costa Vasconcelos; Mônica Virginia Viégas Lima-Aragão; Humberto Oliveira Serra; Rosane Nassar Meireles Guerra Liberio; Ana Paula Silva de Azevedo Dos Santos; Gyl Eanes Barros Silva; Claúdia Quintino da Rocha; Fernando César Vilhena Moreira Lima; Maria do Socorro de Sousa Cartágenes; João Batista Santos Garcia
Journal:  Molecules       Date:  2019-09-25       Impact factor: 4.411

5.  The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study.

Authors:  Ikuko Yataba; Noboru Otsuka; Isao Matsushita; Hideo Matsumoto; Yuichi Hoshino
Journal:  Clin Drug Investig       Date:  2016-08       Impact factor: 2.859
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.